Chinese central SOEs "5 into 3" molding business integration to accelerate - Restructuring - pharmac

Recently, the SAC issued a public notice, said the approval by the State Council, Shanghai Medical Engineering Institute as a whole into Sinopharm, as its wholly-owned subsidiary enterprises. As the central SASAC integrated enterprise platform for medicine, medical engineering at Shanghai Institute won before Sinopharm Biotechnology Corporation of China has in the bag to achieve a central rate of the triple medicine, medicine central rate "5 changed 3", also has become a reality.

The acquisition is completed, after the five Chinese central enterprises?? Sinopharm Group, the Health Group, China Resources Group, Universal Group and Shanghai Pharmaceutical Industry Research Institute, will only Sinopharm, China Resources Group and General Group 3. The next period of time, will form a central Chinese enterprises, "Troika" to keep pace with the pattern.

According to report, just released after the central state-owned enterprises in the capital operating budget for the central enterprises to promote industrial layout and restructuring, etc. The estimated expenditure for 5.9 billion. In accordance with the deployment of the SASAC, 2010, around 140 central enterprises will be reduced to 80-100, peer in the industry, "eat small" acquisitions undoubtedly one of the important ways to reduce the number. Under such pressure, three in the "5 Variable 3" in the surviving company is not easy to become bigger and stronger is the way out.

Joint acquisition of quality assets, the local government
In the "5 into the 3" of the process, whether or Sinopharm Resources are not idle, use two opportunities to find and Local Governments Cooperation Space has become a required course for the two companies.

2009 4 months, Sinopharm to "distant past attack" strategy, eating the most extensive territory covering the west of Xinjiang medicine, this pace of expansion began. Deputy General Manager of letters and more good Sinopharm said: "The circulation, in addition to outside of Tibet and Qinghai, Sinopharm basically covered all the provinces and cities nationwide. The overall layout of Tibet is very difficult, and now Gansu, Qinghai distribution strength has been infiltrated." March 2, Sinopharm and Gansu, Qinghai cooperation solves the problem. In ten days, China Pharmaceutical Group Corporation and the Chengdu Municipal Government in Beijing has signed a strategic cooperation agreement, which means that officially entered the Southwest Sinopharm pharmaceutical market. Song Lin, chairman of China Resources Group

According to introduction, "pharmaceutical industry is focused on the development of China Resources Group, the main industry, is also planning the development of pillar industries in Beijing, China Resources Group since 2006 to accept the SAC re-Huayuan 39, the central enterprises to create medicine platform The mission, in the pharmaceutical industry, to vigorously promote development, have always wanted to be able to integrate the relevant medical resources. "According to industry sources, China Resources will also be carried out in 2010, several large M & A action.

Sinopharm and local governments face pressure to join forces, April 2, 2010, China Resources Group, together with the Beijing People's Government signed a "joint development on the pharmaceutical industry and the micro- Electronic Industry strategic cooperation framework agreement "to jointly promote the biomedical industry and capital, the rapid gathering and microelectronics industry by leaps and bounds, in Beijing to build national bio-pharmaceutical industry and the microelectronics industry base.

Investment adviser in the pharmaceutical industry where researchers Guo Li pointed out that the drug in order to successfully win the North, Beijing, China Resources and the exchange in many areas, the reason why these resources for the North is willing to take medicine, because local governments such as Beijing SASAC control smooth with China Resources to "incorporate" power of life and death north of drugs. Resources for medicine in order to win the North and the other two groups contend, can only be strengthened and the cooperation of local governments, which have become central in the process of merger and reorganization of enterprises means necessary.

Insiders pointed out that China Resources to quickly catch up and a new medicine on Sinopharm Group, for its acquisition of selected parts of the country can only be owned pharmaceutical companies, but no matter the size and efficiency are not better than the North's pharmaceutical drugs and 39 .

And GM group compared to Sinopharm, the new medicine on, CRH, its assets scale and quality of medicine is not high, and the Chinese central rate gap is also larger, General Technology Group To speed up the development must also speed up the integration of Traditional Chinese Medicine good assets, such as last year, the successful holding of Henan General Technology Group Pharmaceutical Industry * ST-day side, is a good signal, so Li Guo any comments.

about author:
We are high quality suppliers, our products such as China foil slitting machine , metal slitters for oversee buyer. To know more, please visits hot foil machine.